Investment bank UBS upgraded Waste Management to a Buy rating from Neutral, highlighting the company’s strengthened financial profile and renewed focus on shareholder returns. The firm cited Waste Management’s completion of key growth investments and the successful integration of Stericycle into its WM Healthcare Solutions division as evidence of its strategic execution. UBS also pointed to the company’s deleveraging efforts—reducing net debt leverage to 3.0x from 3.6x in the fourth quarter of 2024—as a catalyst for the upgrade, underscoring improved balance-sheet flexibility and capacity for capital deployment.

UBS expects Waste Management’s decision to resume share repurchases, suspended since the first quarter of 2024, to drive approximately a 2.5-fold increase in capital returned to investors. This resumption positions the company to redistribute a larger portion of its free cash flow, which UBS projects to grow by more than 30% year-over-year in 2026. The firm believes that a renewed emphasis on buybacks will enhance total shareholder return and support a valuation uplift in the coming year.

Following prior cycles of heavy investment, Waste Management’s relative valuation historically expanded by up to 20% as capital returns rose. While UBS noted its earnings forecasts for 2026 are broadly in line with consensus, the bank anticipates a shift in investor preference toward companies prioritizing shareholder distributions over reinvestment in municipal solid waste infrastructure. This thematic change, combined with expected free cash flow acceleration, is seen as a key driver for a re-rating of Waste Management’s valuation multiple.